Blue Cross Blue Shield Antitrust Litigation
The causation theory is based on economic principles, asserting that collusive agreements among defendants reduced competition, leading to higher prices and limited choices for consumers and providers. This conduct artificially maintained higher costs and suppressed innovation, causing economic injuries as claimed by plaintiffs.
21
Pending actions
109
Total actions filed
Active
Status
12/12/2012
Established
Filing deadline
Initial procedural deadlines were set in court orders from 2013-2014, with the settlement claim deadline passing on July 29, 2025.
Who qualifies
Plaintiffs include individuals and healthcare providers who purchased BCBS insurance or provided services under BCBS plans between February 2008 and October 2020. Eligibility also depends on submitting claims for settlement payouts within the specified deadline.
Products involved
- Blue Cross Blue Shield
- BCBS
- Blue Cross
- Blue Shield
Alleged injuries
- inflated insurance premiums
- reduced provider choice
- limited access to competitive insurance products
Bellwether trials
The bellwether trials were superseded by a settlement of approximately $2.67 billion, which was approved by the court. No individual trials have been conducted or resulted in verdicts.
Settlement landscape
The case settled for about $2.67 billion, with the settlement approved and the settlement claim deadline passing on July 29, 2025. The settlement aims to compensate affected individuals and providers affected by the alleged anti-competitive practices.
Lead counsel
- Tucker Brown
- Jeffrey Gold
- Edgar Gentle
This page is generated from the official JPML pending-MDL report and public court records, refreshed monthly. It is provided for attorney reference and is not legal advice.
